Gut Microbiota, Immune Cell, Colorectal Cancer Association Mediators: a Mendelian Randomization Study

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2025 Mar 4

PMID 40038645

Authors

Yuegang Li

Meng Zhuang

Shiwen Mei

Gang Hu

Jinzhu Zhang

Wenlong Qiu

Xishan Wang

Jianqiang Tang

Affiliations

Soon will be listed here.

Abstract

Background: There have been previously reported associations between the gut microbiota, immune cells, and colorectal cancer; however, the specific mechanisms underlying these relationships remain largely unexplored and require further research. Therefore, in this study, we aimed to unravel the interactions between the gut microbiota, immune cells, and colorectal cancer.

Methods: The analysis used genome-wide association study (GWAS) data encompassing 207 microbial taxa and 205 functional pathways and data on 731 immune cell phenotypes. Colorectal cancer data on 6 581 cases and 463 421 controls were sourced from the Integrative Epidemiology Unit Open GWAS Project. Univariate inverse-variance weighted Mendelian randomization analysis was used to identify gut microbial taxa associated with colorectal cancer. Mediation analysis was used to identify the mediating role of specific immune cells in the link between gut bacteria and colorectal cancer.

Results: Univariate inverse-variance weighted Mendelian randomization analysis revealed that several microbial taxa from the Actinobacteria and Firmicutes phyla were significantly associated with colorectal cancer. Coriobacteriaceae (odds ratio [OR]: 0.84, 95% confidence interval [CI]: 0.72-0.97), Sutterellaceae (OR: 0.88, 95% CI: 0.78-0.99), Eggerthella (OR: 0.91, 95% CI: 0.84-0.99), Coriobacteriales (OR: 0.84, 95% CI: 0.72-0.97), Collinsella aerofaciens (OR: 0.85, 95% CI: 0.74-0.99), and Ruminococcus bromii (OR: 0.91, 95% CI: 0.83-0.99) were negatively associated with colorectal cancer, whereas Lactobacillales (OR: 1.11, 95% CI: 1.03-1.20), Veillonella (OR: 1.08, 95% CI: 1.01-1.15), and Bifidobacterium bifidum (OR: 1.05, 95% CI: 1.00-1.09) were positively associated with colorectal cancer. Mediation analysis revealed that in the causal pathway from Collinsella aerofaciens to colorectal cancer, CD127 on CD28 CD45RA CD8br and human leukocyte antigen (HLA) DR on CD33 HLA DR, mediated 11.30% and - 6.52% of the effect, respectively, and that in the causal pathway from Ruminococcus bromii to colorectal cancer, IgD CD38dim %lymphocyte mediated - 14.80% of the effect.

Conclusions: These results highlight the potential of gut microbiota and immune cell phenotypes as novel treatment strategies for colorectal cancer.

References

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Davies N, Holmes M, Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018; 362:k601. PMC: 6041728. DOI: 10.1136/bmj.k601. View

Rebersek M . Gut microbiome and its role in colorectal cancer. BMC Cancer. 2021; 21(1):1325. PMC: 8666072. DOI: 10.1186/s12885-021-09054-2. View

Ze X, Duncan S, Louis P, Flint H . Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012; 6(8):1535-43. PMC: 3400402. DOI: 10.1038/ismej.2012.4. View

Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

Gronau Q, Wagenmakers E . Limitations of Bayesian Leave-One-Out Cross-Validation for Model Selection. Comput Brain Behav. 2019; 2(1):1-11. PMC: 6400414. DOI: 10.1007/s42113-018-0011-7. View

Ai D, Pan H, Li X, Gao Y, Liu G, Xia L . Identifying Gut Microbiota Associated With Colorectal Cancer Using a Zero-Inflated Lognormal Model. Front Microbiol. 2019; 10:826. PMC: 6491826. DOI: 10.3389/fmicb.2019.00826. View

Lopera-Maya E, Kurilshikov A, van der Graaf A, Hu S, Andreu-Sanchez S, Chen L . Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project. Nat Genet. 2022; 54(2):143-151. DOI: 10.1038/s41588-021-00992-y. View

10.

Li Y, Lai S, Kan X . Causal relationship between immune cells and telomere length: mendelian randomization analysis. BMC Immunol. 2024; 25(1):19. PMC: 10924351. DOI: 10.1186/s12865-024-00610-6. View

11.

Constantinescu A, Bull C, Jones N, Mitchell R, Burrows K, Dimou N . Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study. Int J Cancer. 2023; 154(1):94-103. PMC: 10864681. DOI: 10.1002/ijc.34691. View

12.

Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L . Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 2022; 54(1):52-61. DOI: 10.1038/s41588-021-00968-y. View

13.

Chen Y, Wang X, Ye Y, Ren Q . Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies. Med Oncol. 2023; 41(1):25. DOI: 10.1007/s12032-023-02249-6. View

14.

Feitelson M, Arzumanyan A, Medhat A, Spector I . Short-chain fatty acids in cancer pathogenesis. Cancer Metastasis Rev. 2023; 42(3):677-698. PMC: 10584782. DOI: 10.1007/s10555-023-10117-y. View

15.

Campbell C, Kandalgaonkar M, Golonka R, Yeoh B, Vijay-Kumar M, Saha P . Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines. 2023; 11(2). PMC: 9953403. DOI: 10.3390/biomedicines11020294. View

16.

Hedblom G, Reiland H, Sylte M, Johnson T, Baumler D . Segmented Filamentous Bacteria - Metabolism Meets Immunity. Front Microbiol. 2018; 9:1991. PMC: 6117376. DOI: 10.3389/fmicb.2018.01991. View

17.

Yang J, Ferreira T, Morris A, Medland S, Madden P, Heath A . Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012; 44(4):369-75, S1-3. PMC: 3593158. DOI: 10.1038/ng.2213. View

18.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

19.

Skrivankova V, Richmond R, Woolf B, Yarmolinsky J, Davies N, Swanson S . Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021; 326(16):1614-1621. DOI: 10.1001/jama.2021.18236. View

20.

Richiardi L, Bellocco R, Zugna D . Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol. 2013; 42(5):1511-9. DOI: 10.1093/ije/dyt127. View